ID29574A - Formulasi 2-metil-tieno-benzodiazepin - Google Patents

Formulasi 2-metil-tieno-benzodiazepin

Info

Publication number
ID29574A
ID29574A IDW20010679A ID20010679A ID29574A ID 29574 A ID29574 A ID 29574A ID W20010679 A IDW20010679 A ID W20010679A ID 20010679 A ID20010679 A ID 20010679A ID 29574 A ID29574 A ID 29574A
Authority
ID
Indonesia
Prior art keywords
formulation
tieno
benzodiazepin
methyl
olanzapine
Prior art date
Application number
IDW20010679A
Other languages
English (en)
Indonesian (id)
Inventor
Charles Arthur Bunnell
Thomas Harry Ferguson
Barry Arnold Hendriksen
David Edward Tupper
Manuel Vicente Sanchez-Felix
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/163,769 external-priority patent/US6169084B1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID29574A publication Critical patent/ID29574A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW20010679A 1998-09-30 1999-03-24 Formulasi 2-metil-tieno-benzodiazepin ID29574A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16376898A 1998-09-30 1998-09-30
US09/163,769 US6169084B1 (en) 1997-09-30 1998-09-30 2-methyl-thieno-benzodiazepine formulation

Publications (1)

Publication Number Publication Date
ID29574A true ID29574A (id) 2001-09-06

Family

ID=26859927

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010679A ID29574A (id) 1998-09-30 1999-03-24 Formulasi 2-metil-tieno-benzodiazepin

Country Status (28)

Country Link
EP (1) EP1119359B1 (xx)
JP (1) JP4551988B2 (xx)
CN (1) CN1146422C (xx)
AT (2) ATE359793T1 (xx)
AU (1) AU759751B2 (xx)
BR (1) BR9914156A (xx)
CA (1) CA2344873A1 (xx)
CZ (1) CZ302367B6 (xx)
DE (2) DE69935873T2 (xx)
DK (2) DK1468689T3 (xx)
EA (1) EA002580B1 (xx)
ES (2) ES2285294T3 (xx)
GE (1) GEP20094818B (xx)
HK (1) HK1041199B (xx)
HR (1) HRP20010238B1 (xx)
HU (1) HU227400B1 (xx)
ID (1) ID29574A (xx)
IL (2) IL141766A0 (xx)
MY (1) MY126476A (xx)
NO (1) NO328243B1 (xx)
NZ (1) NZ510208A (xx)
PL (1) PL196821B1 (xx)
PT (2) PT1468689E (xx)
SK (1) SK285944B6 (xx)
TR (1) TR200100885T2 (xx)
TW (1) TW577890B (xx)
UA (1) UA66872C2 (xx)
WO (1) WO2000018408A1 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60019461T2 (de) * 1999-12-28 2005-09-22 Cipla Ltd., Bombay Neue polymorphe formen von olanzapin
US7022698B2 (en) 1999-12-28 2006-04-04 U & I Pharmaceuticals, Ltd. Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
PL196814B1 (pl) 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
HU226410B1 (en) * 2003-04-22 2008-11-28 Egis Gyogyszergyar Nyilvanosan Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
US20080009481A1 (en) * 2004-07-14 2008-01-10 Shasun Chemicals And Drugs Limited Process For Making Form I Of Olanzapine
ES2253091B1 (es) * 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
US20090155331A1 (en) * 2005-11-16 2009-06-18 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
CA2587710C (en) * 2004-11-16 2014-10-21 Elan Pharma International Ltd. Injectable nanoparticulate olanzapine formulations
DK1838716T3 (da) * 2005-01-05 2011-07-25 Lilly Co Eli Olanzapinpamota-dihydrat
CZ2006697A3 (cs) * 2006-11-07 2008-05-21 Zentiva, A. S. Kompozice depotních olanzapinových injekcních systému
FR2927965B1 (fr) * 2008-02-22 2010-06-04 Valeo Materiaux De Friction Sa Procede de fabrication d'un materiau de friction et notamment d'une couronne de friction d'embrayage.
RU2548753C2 (ru) * 2009-11-16 2015-04-20 Ипсен Фарма С.А.С. Фармацевтические композиции лигандов рецепторов меланокортинов
WO2011091142A2 (en) * 2010-01-20 2011-07-28 Teva Pharmaceutical Industries Ltd. Crystalline and amorphous forms of olanzapine pamoate
US9469630B2 (en) 2010-10-18 2016-10-18 Sumitomo Dainippon Pharma Co., Ltd. Sustained-release formulation for injection
EP2956456B1 (en) 2013-02-13 2017-07-12 Neuland Laboratories Ltd A process for preparation of olanzapine pamoate
CN105044231B (zh) * 2015-06-27 2022-09-13 万特制药(海南)有限公司 一种分离测定奥氮平双羟萘酸盐一水合物有关物质的方法
CA3057438A1 (en) 2017-03-20 2018-09-27 Teva Pharmaceuticals International Gmbh Sustained release olanzapine formulaitons

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2095499A1 (en) * 1992-05-08 1993-11-09 Petrus J. M. Van Den Oetelaar Depot preparation
WO1994010982A1 (en) * 1992-11-17 1994-05-26 Yoshitomi Pharmaceutical Industries, Ltd. Sustained-release microsphere containing antipsychotic and process for producing the same
TW376319B (en) * 1993-04-28 1999-12-11 Janssen Pharmaceutica Nv Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
PL194074B1 (pl) * 1996-09-23 2007-04-30 Lilly Co Eli Polimorf Dihydrat D olanzapiny i preparat farmaceutyczny zawierający Dihydrat D olanzapiny
PL339864A1 (en) * 1997-09-30 2001-01-15 Lilly Co Eli Preparation containing 2-methylthiene benzodiazepin

Also Published As

Publication number Publication date
BR9914156A (pt) 2001-06-26
UA66872C2 (uk) 2004-06-15
DK1119359T3 (da) 2004-08-16
HUP0103636A2 (hu) 2002-01-28
PL196821B1 (pl) 2008-02-29
CZ302367B6 (cs) 2011-04-13
EP1119359B1 (en) 2004-05-26
ATE267602T1 (de) 2004-06-15
EA200100406A1 (ru) 2001-10-22
DE69935873D1 (de) 2007-05-31
PT1468689E (pt) 2007-07-09
HK1041199A1 (en) 2002-07-05
DE69917663T2 (de) 2005-05-25
JP2002525330A (ja) 2002-08-13
DK1468689T3 (da) 2007-08-13
CZ20011149A3 (cs) 2002-01-16
WO2000018408A1 (en) 2000-04-06
PL346981A1 (en) 2002-03-11
DE69917663D1 (de) 2004-07-01
HRP20010238B1 (en) 2006-05-31
MY126476A (en) 2006-10-31
IL141766A (en) 2006-12-31
NO328243B1 (no) 2010-01-11
HUP0103636A3 (en) 2003-05-28
TR200100885T2 (tr) 2001-08-21
SK4162001A3 (en) 2002-03-05
EP1119359A1 (en) 2001-08-01
DE69935873T2 (de) 2008-01-10
AU3362799A (en) 2000-04-17
ES2221376T3 (es) 2004-12-16
EP1119359A4 (en) 2001-12-19
NO20011583D0 (no) 2001-03-28
CN1146422C (zh) 2004-04-21
NO20011583L (no) 2001-03-28
HK1041199B (zh) 2005-03-18
CN1320038A (zh) 2001-10-31
EA002580B1 (ru) 2002-06-27
JP4551988B2 (ja) 2010-09-29
AU759751B2 (en) 2003-05-01
IL141766A0 (en) 2002-03-10
CA2344873A1 (en) 2000-04-06
NZ510208A (en) 2003-04-29
ES2285294T3 (es) 2007-11-16
HU227400B1 (en) 2011-05-30
PT1119359E (pt) 2004-08-31
SK285944B6 (sk) 2007-11-02
HRP20010238A2 (en) 2002-04-30
TW577890B (en) 2004-03-01
ATE359793T1 (de) 2007-05-15
GEP20094818B (en) 2009-11-10

Similar Documents

Publication Publication Date Title
TR200000812T2 (tr) 2-metil-tieno- benzodiazepin formülasyonu.
DE69935873D1 (de) 2-Methyl-thieno-benzodiazepin Formulierung
NO20010556D0 (no) Fremgangsmåte for oftalmisk administrering
YU15499A (sh) Olanzapin dihidrat d
EA199900373A2 (ru) Фармацевтические композиции
TR199800759T2 (xx) Protein Kinaz C �nhibit�r�.
RS49688B (sr) Novi derivat 3-aril-2- hidroksipropionske kiseline (i)
YU15299A (sh) Farmaceutski sastavi
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
IT1307928B1 (it) Metodo di sintesi di nitrossimetilfenil esteri di derivatidell'aspirina.
NL1006065A1 (nl) Inlegkruisje voor stringslip.
DK1073447T3 (da) N1-modificerede glycopeptider
ECSP992901A (es) Formulacion de 2- metil -tieno benzodiazepina
ECSP972052A (es) Quinoxalinadionas
ITMI982242A0 (it) Procedimento per la preparazione di un derivato dell'isobenzofurano
IT239670Y1 (it) Idro-contenitore per l'innalzamento provvisorio di argini.
IT1287349B1 (it) Pertica per il livellamento di superfici intonacate.
IT1287307B1 (it) Pertica per il livellamento di superfici intonacate.
ES2196503T3 (es) Procedimientos e intermedios para la preparacion de pirrolo(3,2-b)piridinas.
UA25365A (uk) Спосіб профілактики вториhhої катаракти
ECSP982785A (es) Nuevos compuestos de tetrahidroizoquinoleinil- carboxamida, de formula (i) y procedimiento para su obtencion
ITMI981691A1 (it) Composizioni farmaceutiche atte alla sommistrazione per via transdermale di apomorfina
ITMI970682A0 (it) Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4- tetraidroisochinolin-3- carbossiammide